DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Taspoglutide
Taspoglutide
Albiglutide Needs Greater Accuracy from Remaining Shots on Goal
Combination Use of Insulin and Incretins in Type 2 Diabetes
Efficacy and Safety of Taspoglutide Versus Sitagliptin
PYY(3-36) Analogues: Structure
Sanofi Forced to Defend Lantus' Safety Again
Hypoglycemia & Hyperglycemia
Science Report 2010
A Meta-Analysis Comparing Clinical Effects of Short
Structure and Dynamics of Semaglutide and Taspoglutide Bound GLP-1R-Gs Complexes Xin Zhang1, Matthew J
The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes the T-Emerge 2 Trial
Benefits and Harms of Once-Weekly Glucagon-Like Peptide-1
Metabolic Disease
(INN) for Biological and Biotechnological Substances
Taspoglutide for Type 2 Diabetes Mellitus – Add-On Therapy August
Protocol Bc21625)
Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2
Long-Acting Glucagon-Like Peptide 1 Receptor Agonists a Review of Their Efficacy and Tolerability
Annual Report Art 50 2018
Top View
The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates
Efficacy and Safety Profile of Once-Weekly Dulaglutide in Type 2 Diabetes: a Report on the Emerging New Data
GLP-1 Agonists Jostling for Position
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
The Efficacy of Placebo-Adjusted Taspoglutide on Body Weight
Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary
Treatment with the Human Once-Weekly Glucagon-Like
Diagnosis and Management of Horses with Equine Metabolic Syndrome (EMS)
Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes
Diagnosis and Management of Horses with Equine Metabolic Syndrome (EMS) Kelly Ann Chameroy
[email protected]
Ipsen's Partner Roche Confirms the Promising Efficacy Profile Of
Therapeutic Class Overview Insulins
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
Glucagon-Like Peptide-1 and Its Class BG Protein–Coupled Receptors
Advances in Therapeutic Peptides Targeting G Protein-Coupled Receptors
125469Orig1s000
Approaches to the Pharmacological Treatment of Obesity
New Anti-Obesity Drugs on the Horizon